Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 2Genitourinary 2Gastrointestinal 2CNS 2Other solid neoplasm 1Lymphoid 1Gynecologic 1

Conditions

Unspecified Childhood Solid Tumor, Protocol Specific 1Solid Tumor 1Sarcoma 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Neoplasms, Germ Cell and Embryonal 1Medulloblastoma 1Hepatoblastoma 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1Brain Neoplasms 1

Interventions

pembrolizumab 10Nivolumab 5Granulocyte Colony-Stimulating Factor 4atezolizumab 3Ipilimumab 3Ifosfamide 3Etoposide 3tislelizumab 2sargramostim 2durvalumab 2Thiotepa 2Paclitaxel 2Mesna 2Melphalan 2Filgrastim 2Docetaxel 2Cyclophosphamide 2Carboplatin 2Busulfan 2tazemetostat 1spartalizumab 1regorafenib 1pegylated granulocyte colony-stimulating factor 1obinutuzumab 1niraparib 1naptumomab estafenatox 1milademetan 1etoposide phosphate 1epacadostat 1enzalutamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Renal Cell × etoposide phosphate × Other solid neoplasm × Clear all
NCT01505569 2024-02-26

Auto Transplant for High Risk or Relapsed Solid or CNS Tumors

Masonic Cancer Center, University of Minnesota

Phase NA Completed
44 enrolled
CNSGastrointestinalGenitourinaryOther solid neoplasmSarcoma

Brain Neoplasms, Carcinoma, Renal Cell, Medulloblastoma, Neoplasms, Germ Cell and Embryonal, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Central Nervous System Neoplasms, Hepatoblastoma, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡